Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity

Vaccine

Volumn 15, Issue 15, 1997, Pages 1624-1630

  Del Canho, R ^a   Grosheide, P M ^a   Mazel, J A ^b   Heijtink, R A ^c   Hop, W C J ^c   Gerards, L J ^d   De Gast, G C ^e   Fetter, W P F ^f   Zwijneberg, J ^g   Schalm, S W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Gezondheidscentrum Ommoord   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f Sophia Hospital   (Netherlands)

^g Ruwaard Van Putten Hospital   (Netherlands)

Author keywords

Hepatitis B; Hepatitis B immunoglobulin; Meta analysis; Neonates; Randomized contolled trials; Recombinant; Vaccine plasma

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MAJOR CLINICAL STUDY; META ANALYSIS; METHODOLOGY; NETHERLANDS; NEWBORN; NEWBORN HEPATITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; NETHERLANDS; PREGNANCY; TIME FACTORS; VACCINATION;

EID: 0030747213     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00080-7     Document Type: Article

References (22)

1. Mazel, J.A., Schalm, S.W., de Gast, B.C., Nuijten, A.S.M., Heijtink, R.A., Botman, M.J., Bänffer, J.R.J., Gerards, L.J., Zwijnenberg, J., Mettau, J., Wladimiroff, YW. and Fetter, W.P.F. Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations. British Medical Journal 1984, 288, 513-515.
2. Schalm, S.W., Mazel, J.A., de Gast, G.C., Heijtink, R.A., Botman, M.J. and Bänffer, J.R.J. et al. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics 1989, 83, 1041-1048.
3. Grosheide, P.M., del Canho, R., Voogd, M , Heijtink, R.A., Schalm, S.W. and Dutch Study Group Prevention Neonatal Hepatitis B, Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-Polio vaccine: Is there need for a second dose of HBIg? Vaccine 1994, 12, 1059-1063.
4. del Canho, R., Grosheide, P.M., Schalm, S.W., de Vries, R.R.P. and Heijtink, R.A. Failure of neonatal hepatitis B vaccination: The role of HBV DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. Journal of Hepatology 1994, 20, 483-486.
5. Lee, S.D., Lo, K.J., Wu, J.C., Tsai, Y.T., Wang, J.Y. and Ting, L.P. et al. Prevention of maternal-infant hepatitis B virus transmission by immunization: The role of serum hepatitis B virus DNA. Hepatology 1986, 6, 369-373.
6. Ip, H.M.H., Lelie, P.N., Wong, V.C.W., Kuhns, M.C. and Reesink, H.W. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989, i, 406-410.
7. Lin, H.H., Chang, M.H., Chen, D.S., Sung, J.L., Hong, K.H. and Young, Y.C. et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991, 9, 457-460.
8. Altman, D.G. Practical Statistics for Medical Research. Chapman and Hall, London, 1995, pp. 351-358.
9. Beasley, R.P., Hwang, L.Y., Lee, G.C., Lan, C., Roan, C. and Huang, F. et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983, ii, 1099-1102.
10. Wong, V.C.W., Ip, H.M.H., Reesink, H.W., Lelie, P.N., Reerink-Brongers, E.E. and Yeung, C.Y. et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1984, i, 921-926.
11. Coursaget, P., Yvonnet, B., Chotard, J., Sarr, M., Vincelot, P. and N'doye, R. et al. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986, ii, 1143-1145.
12. Stevens, C.E., Taylor, P.E., Tong, M.J., Toy, P.T., Vyas, G.N. and Nair, P.V. et al. Yeast-recombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987, 257, 2612-2616.
13. Poovorawan, Y., Sanpavat, S., Pongpuniert, W., Chumdermpadetsuk, S., Sentrakul, P. and Safary, A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 1989, 261, 3278-3281.
14. Marion, S.A., Tomm Pastore, M., Pi, D.W. and Mathias, R.G. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. American Journal of Epidemiology 1994, 140, 734-746.
15. Carman, W.F., Zanetti, A.R., Karayiannis, P., Waters, J., Manzillo, G. and Tanzi, E. et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336, 325-329.
16. Stevens, C.E., Toy, P.T., Taylor, P.E., Lee, T. and Yip, H.Y. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 1992, 90, 170-173.
17. Lieming, D., Mintai, Z., Yinfu, W., Shaochon, Z., Weiqin, K. and Smego, R.A. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. Clin. Inf. Dis. 1993, 17, 475-479.
18. Lo, K.J., Lee, S.D., Tsai, Y.T., Wu, T.C., Chan, C.Y. and Chen, G.H. et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology 1988, 8, 1647-1650.
19. Hadlèr, S.C., Francis, D.P., James, D.S., Maynard, J.E., Thompson, S.E. and Judson, F.N. et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. New England Journal of Medicine 1986, 315, 209-214.
20. Workshop Report, Immunisation against, hepatitis B. Lancet 1988, 1, 875-876
21. Okada, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y. and Mayumi, M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. New England Journal of Medicine 1976, 294, 746-749.
22. Beasley, R.P. and Hwang, L.Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. Journal of Infectious Diseases 1983, 147, 185-190.